The FDA/DEA are coming after your CII opiates !!
This is their REMS program.. IM ...many docs will just drop back to prescribing Hydrocodone/APAP and NSAIDS
The US Food and Drug Administration's (FDA's) controversial opioid risk evaluation and mitigation strategies, known as REMS, are in the final stages of development and could be ready this summer.
The plan will alter the prescribing landscape for opioid therapies and is expected to have important implications for clinicians, the patients who use these drugs, and the companies that make them.
The agency has yet to release details about the new plan, but this weekend Bob Rappaport, MD, from the FDA's Center for Drug Evaluation and Research hinted it will include mandatory education.
Speaking here at the American Pain Society 29th Annual Scientific Meeting, Dr. Rappaport said he is unable to confirm any details but suggested that education will factor prominently.
Dr. Bob Rappaport, FDA
"Physician and patient education would be the most beneficial component," he said. "Clinicians could be educated to maintain prescribing privileges for CII opioids and must be willing to require their patients be engaged in safety messaging."
|